
Global Hemp Group Inc. — Investor Relations & Filings
Global Hemp Group Inc. focuses on two key segments: Industrial Hemp and Biopharma. The Industrial Hemp division develops innovative, green, and sustainable solutions utilizing the whole hemp plant for environmental applications, including carbon-negative construction materials, sustainable bio-energy sources, bio-composites, textiles, and nonwovens. This strategy is executed through the Hemp Agro-Industrial Zone (HAIZ) concept, which integrates raw material supply with industrial processing. The company also maintains an R&D division dedicated to developing patented IP for hemp-based eco-friendly building materials. The Biopharma division centers on acquiring exclusive licensing of advanced Intellectual Property, notably holding exclusive perpetual licenses to Apollon Formularies' proprietary technology and patents for developing cancer treatments from natural biologics (such as medical cannabis and functional mushrooms) using an AI-based drug discovery platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2025-10-09 | English | |
| News release - English.pdf | 2025-04-08 | English | |
| News release - English.pdf | 2025-03-27 | English | |
| News release - English.pdf | 2025-03-18 | English | |
| News release - English.pdf | 2025-03-13 | English | |
| News release - English.pdf | 2025-02-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
13 filings
| |||||
| 32343196 | News release - English.pdf | 2025-10-09 | English | ||
| 13784058 | News release - English.pdf | 2025-04-08 | English | ||
| 13780675 | News release - English.pdf | 2025-03-27 | English | ||
| 13777976 | News release - English.pdf | 2025-03-18 | English | ||
| 13777388 | News release - English.pdf | 2025-03-13 | English | ||
| 13771229 | News release - English.pdf | 2025-02-27 | English | ||
| 31698288 | News release - English.pdf | 2025-02-13 | English | ||
| 31642029 | News release - English.pdf | 2025-01-30 | English | ||
| 13766220 | Report of exempt distribution (45-106F1).pdf | 2025-01-28 | English | ||
| 13765230 | Material change report - English.pdf | 2025-01-20 | English | ||
| 13765424 | News release - English.pdf | 2025-01-18 | English | ||
| 13764767 | News release - English.pdf | 2025-01-11 | English | ||
| 13764325 | News release - English.pdf | 2025-01-07 | English | ||
|
2024
2 filings
| |||||
| 13762019 | News release - English.pdf | 2024-12-12 | English | ||
| 13762017 | News release - English.pdf | 2024-12-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Dyne Therapeutics, Inc.
Develops targeted therapies for genetically driven neuromus…
|
DYN | US | Manufacturing |
|
Eagle Veterinary Technology Co.,Ltd
Manufactures veterinary pharmaceuticals and develops premiu…
|
044960 | KR | Manufacturing |
|
EastWest Bioscience Inc.
Vertically integrated seed-to-sale wellness company for pre…
|
EAST.H | CA | Manufacturing |
|
Eckert & Ziegler Strahlen- und Medizintechnik AG
A global provider of isotope technology for medical, scient…
|
EUZ | DE | Manufacturing |
|
ECO ANIMAL HEALTH GROUP PLC
Develops and markets pharmaceuticals and biologicals for pi…
|
EAH | GB | Manufacturing |
|
Edesa Biotech, Inc.
Clinical-stage biopharma developing therapies for inflammat…
|
EDSA | US | Manufacturing |
|
Edgewise Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for rare m…
|
EWTX | US | Manufacturing |
|
Egetis Therapeutics
Develops and commercializes treatments for serious and rare…
|
EGTX | SE | Manufacturing |
|
EIKEN CHEMICAL CO.,LTD.
Manufacturer of clinical diagnostics, medical equipment, an…
|
4549 | JP | Manufacturing |
|
EirGenix
Integrates CDMO services with proprietary biosimilar and ca…
|
6589 | TW | Manufacturing |
Global Hemp Group Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46553/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46553 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46553 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46553 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46553}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Global Hemp Group Inc. (id: 46553)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.